Reena Khanna

Follow

Generating author description...

All published works

Action	Title	Year	Authors
+	The Clinical Interpretation of Cluster Trials	2024	Pavel S Roshanov Guangyong Zou Reena Khanna
+	The Clinical Interpretation of Noninferiority Trials	2023	Pavel S Roshanov Reena Khanna
+ PDF Chat	Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology—The Trends of Disease Over Time	2021	Stephanie Coward Joseph W. Windsor M Ellen Kuenzig Alain Bitton Çharles N. Bernstein Jennifer Jones Reena Khanna Leena Peltonen Sanjay K. Murthy Laura E. Targownik

Common Coauthors

Coauthor	Papers Together
Pavel S Roshanov	2
M Ellen Kuenzig	1
Çharles N. Bernstein	1
James Guoxian Huang	1
Gilaad G. Kaplan	1
Alain Bitton	1
Parul Tandon	1
Stephanie Coward	1
Eric I. Benchimol	1
Laura E. Targownik	1
Sanjay K. Murthy	1
Guangyong Zou	1
Jennifer Jones	1
Mariam S Mukhtar	1
Joseph W. Windsor	1
Leena Peltonen	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+ PDF Chat	Cluster randomised trials in the medical literature: two bibliometric surveys	2004	Martin Bland	1
+	Covariate-based constrained randomization of group-randomized trials	2004	Lawrence H. Moulton	1
+	RANDOMIZATION BY CLUSTER	1981	Allan Donner Nicholas Birkett Carol Buck	1
+ PDF Chat	Through the looking glass: understanding non-inferiority	2011	Jennifer Schumi Janet Wittes	1
+	Seven myths of randomisation in clinical trials	2012	Stephen Senn	1
+	On stratification, minimization and protection against types 1 and 2 error	2001	Michael B. Bracken	1
+	Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China	2020	Zunyou Wu Jennifer M. McGoogan	1
+ PDF Chat	High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2	2020	Steven Sanche Yen Ting Lin Chonggang Xu Ethan Romero-Severson Nicolas Hengartner Ruian Ke	1
+ PDF Chat	Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period	2020	Stephen M. Kissler Christine Tedijanto Edward Goldstein Yonatan H. Grad Marc Lipsitch	1
+ PDF Chat	Modeling shield immunity to reduce COVID-19 epidemic spread	2020	Joshua S. Weitz Stephen J. Beckett Ashley R. Coenen David Demory Marian Dominguez-Mirazo Jonathan Dushoff Chung Yin Leung Guanlin Li Andreea Măgălie Sang Woo Park	1
+ PDF Chat	Assessment of the Regulatory Dialogue Between Pharmaceutical Companies and the European Medicines Agency on the Choice of Noninferiority Margins	2020	Turki A. Althunian Anthonius de Boer Aukje K. Mantel‐Teeuwisse Rolf H. H. Groenwold Christine C. Gispen‐de Wied Hubert G. M. Leufkens Olaf H. Klungel	1
+	Trends in Number and Distribution of COVID-19 Hotspot Counties — United States, March 8–July 15, 2020	2020	Alexandra M. Oster Gloria J. Kang Amy E Vladislav Beresovsky Charles E. Rose Gabriel Rainisch Laura S. Porter Eduardo Valverde Elisha B. Peterson Anne K. Driscoll	1
+	Noninferiority margins exceed superiority effect estimates for mortality in cardiovascular trials in high-impact journals	2023	Sandra Ofori Teresa Cafaro P.J. Devereaux Maura Marcucci Lawrence Mbuagbaw Lehana Thabane Gordon Guyatt	1